Representative before the EPO

Employment test 51 - 200 employees
Company dna bardehle pagenberg
operating since 1979
Headquarter in Munich and 3 offices
active in Legal Services

We have observed 4 EP applications Axel Bernhard Berger has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 18, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13729324

BENDAMUSTINE DERIVATIVES AND RELATED COMPOUNDS, AND MEDICAL USE THEREOF CANCER THERAPY

IPC classification:
A61K 31/4184, A61P 35/00, C07D 235/12
Agent:
Axel Bernhard Berger, Bardehle Pagenberg Partnerschaft mbB
Agent:
LifeTech IP, Spies Danner & Partner, Patentanwälte PartG mbB
Agent:
Kopf Westenberger Wachenhausen Patentanwälte PartG mbB
Agent:
Lorenz & Kopf PartG mbB (LKGLOBAL)
Status:
EXAMINATION IN PROGRESS
EP15173283

METHOD FOR THE SYNTHESIS OF RAPAMYCIN DERIVATIVES

IPC classification:
C07D 498/18
Agent:
Axel Bernhard Berger, Bardehle Pagenberg Partnerschaft mbB
Agent:
Kopf Westenberger Wachenhausen Patentanwälte PartG mbB
Agent:
Lorenz & Kopf PartG mbB (LKGLOBAL)
Status:
APPLICATION PUBLISHED
EP15175659

METHOD FOR THE SYNTHESIS OF PENTOSTATIN

IPC classification:
C12P 17/00, C12P 19/28
Agent:
Axel Bernhard Berger, Bardehle Pagenberg Partnerschaft mbB
Agent:
Kopf Westenberger Wachenhausen Patentanwälte PartG mbB
Agent:
Lorenz & Kopf PartG mbB (LKGLOBAL)
Status:
APPLICATION PUBLISHED
EP15717892

METHOD FOR THE SYNTHESIS OF CLOFARABINE

IPC classification:
C12P 17/18, C12P 19/40
Agent:
Axel Bernhard Berger, Bardehle Pagenberg Partnerschaft mbB
Agent:
Kopf Westenberger Wachenhausen Patentanwälte PartG mbB
Agent:
Lorenz & Kopf PartG mbB (LKGLOBAL)
Status:
The patent has been granted

Please Sign in to use this feature